🇺🇸 FDA
Pipeline program

Nocardia rubra Cell Wall Skeleton

XYFY2021-KL151-01

Approved small_molecule active

Quick answer

Nocardia rubra Cell Wall Skeleton for Diabetic Foot Ulcer is a Approved program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
First Tracks Biotherapeutics
Indication
Diabetic Foot Ulcer
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials